An observational study in Sleep Disorder (Disorder) and Cardio Vascular Disease, sponsored by French Cardiology Society. Recruiting at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-25.
Sponsored by French Cardiology Society · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 65 studies in Sleep Wake Disorders with a site in France — 22 open to participants now, 27 under way, 4 of them phase 3. Sleep Wake Disorders · France.
Among the 65 studies in Sleep Wake Disorders with a site in France, this one has the largest planned enrollment of the 23 observational ones that give a count, is one of 9 that started in 2026, is one of 23 observational ones, reaches primary completion later than 14 of the 26 other live ones, and was the 59th registered.
747 studies on the registry are indexed under Sleep Wake Disorders; 181 are open to participants now.
Browse Sleep Wake Disorders studies →22 of the 65 studies in Sleep Wake Disorders with a site in France are open now. Recruiting first, the newest first:
Replior AB · Sites in France
Ages 18–65
Direction Centrale du Service de Santé des Armées · Sites in France
Ages 18–65
Alkermes, Inc. · Sites in France, United States, Australia and 11 more countries
Ages 18–70
Alkermes, Inc. · Sites in France, United States, Australia and 12 more countries
Ages 18–70
University Hospital, Toulouse · Sites in France
Ages 18–65 · Healthy volunteers
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 114 Sleep Wake Disorders studies recruiting now, 40 (35%) set no upper age limit and 53 (46%) stop at 75 or younger; 22 take children under 18; 28 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
65 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 6 · Phase 3 6 · Phase 4 2
First in 2009; this study’s year is marked. 9 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,500 is above the median of 120 across 197 observational studies indexed under Sleep Wake Disorders.
Median enrollment 87 across the 42 interventional studies, 100 across the 23 observational. Of the 31 that completed or were terminated, 2 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
12 of 65 have an industry lead sponsor. The 10 most frequent:
French Cardiology Society is the lead sponsor of 85 studies on the registry; 16 are open to participants now.
French Cardiology Society has 1 study filed under Sleep Wake Disorders — fewer than ten, so there is no comparison to draw.
14 of the studies in Sleep Wake Disorders with a site in France that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07502443Phase 3Alkermes, Inc.A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2 | 2027-05 |
| NCT07455383Phase 3Alkermes, Inc.A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 | 2027-05 |
| NCT06843590Alkermes, Inc.A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia | 2026-11 |
| NCT07628959Centre Hospitalier Universitaire de Saint EtienneInnovative Sleep Quality Analysis Software Compared With Polysomnography | 2026-12 |
| NCT07909967Replior ABObservational Analytical Validation Study of the Replior ScratchSense | 2026-12-10 |
Add all 14 to your calendar (.ics) → With an account.
Among the 65 studies in Sleep Wake Disorders with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this observational study is to validate a simplified questionnaire, adapted for routine clinical use, to quickly detect sleep disorders in patient during a cardiology consultation.
Two questionnaires were developed for this project. The first is patient-oriented: a prospective, multicentre, national observational registry based on a patient questionnaire designed to quickly detect sleep disorders during a cardiology consultation.
The second is aimed at treating cardiologists: this is a simple impact survey designed to assess changes in the practices of cardiologists who participated in CARDIOSOM.
Adult patients consulting in cardiology and cardiologists who participated in CARDIOSOM and perform cardiology consultations
Inclusion Criteria - Patient :
Inclusion Criteria - Cardiologist:
Cardiologists who participated in CARDIOSOM and who conduct cardiology consultations that include a systematic or non-systematic assessment of their patients' sleep quality (duration, regularity, insomnia, sleepiness, suspected obstructive sleep apnea (OSA)) and whether or not suspected sleep disorders in patients are treated.
Exclusion Criteria - Patient :
Exclusion Criteria - Cardiologist :
Not applicable
a prospective, multicentre, national observational survey based on a patient questionnaire designed to quickly detect sleep disorders during a cardiology consultation.
Other: Online questionnaire
this is a simple impact survey designed to assess changes in the practices of cardiologists who participated in CARDIOSOM.
Other: Online questionnaire
Patient oriented Online questionnaire
Cardiologist oriented online questionnaire
Overall prevalence of sleep disorders among patients consulting a cardiologist
online questionnaire completed by the patient
Time frame: on day 0 (day of completing the online questionnaire)
Describe the sleep complaints and disorders reported by patients consulting a cardiologist.
online questionnaire completed by the patient
Time frame: on day 0 (day of completing the online questionnaire)
Identify the types of sleep disorders associated with the presence of cardiovascular diseases.
online questionnaire completed by the patient
Time frame: on day 0 (day of completing the online questionnaire)
Studying the influence of gender on sleep disorders and cardiovascular diseases
online questionnaire completed by the patient
Time frame: on day 0 (day of completing the online questionnaire)
Studying the influence of socioeconomic determinants on sleep disorders and cardiovascular diseases
online questionnaire completed by the patient
Time frame: on day 0 (day of completing the online questionnaire)
Assess how often cardiologists routinely ask patients about their sleep quality
online questionnaire completed by the cardiologist
Time frame: at inclusion and one year after
Determine whether or not to treat suspected sleep disorders in patients during their cardiology consultations.
online questionnaire completed by the cardiologist
Time frame: at inclusion and one year after
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Jan 2027, 12 months after the start.
Of 71 non-industry observational studies under Sleep Wake Disorders, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 47. This study's planned 12 months is below that.
Counting every sponsor, half of 82 studies reached it within 25 months; a quarter within 12 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
French Cardiology Society